Cargando...
Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease
Hydroxyurea is an excellent therapeutic agent for the pharmacological induction of HbF in patients with sickle cell disease (SCD). However, all completed clinical trials of hydroxyurea have excluded patients with hemoglobin SC (HbSC) disease. HbSC differs significantly in pathophysiology from HbSS,...
Gardado en:
| Publicado en: | Exp Biol Med (Maywood) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950384/ https://ncbi.nlm.nih.gov/pubmed/26993671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370216639737 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|